The histiocytoses: the fall of the Tower of Babel (Q33742989)

29 July 2017

1 reference

title

The histiocytoses: the fall of the Tower of Babel (English)

1 reference

29 July 2017

Arceci RJ

1

1 reference

29 July 2017

publication date

1 May 1999

1 reference

European Journal of Cancer

29 July 2017

published in

1 reference

29 July 2017

volume

35

1 reference

29 July 2017

issue

5

1 reference

29 July 2017

page(s)

747-67; discussion 767-9

1 reference

Langerhans cell (eosinophilic) granulomatosis. A clinicopathologic study encompassing 50 years

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

The cytological identity and interrelation of mesenchymal cells of lymphoid tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Ueber die Nerven der menschlichen Haut

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Immunogenicity: role of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Initiation of hemopoiesis in the mouse embryo.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Para-aortic splanchnopleura from early mouse embryos contains B1a cell progenitors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Definitive hematopoiesis is autonomously initiated by the AGM region

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Nosology and pathology of Langerhans cell histiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Dendritic cells: origin and differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Langerhans cell histiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Langerhans cell histiocytosis. Historical perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Familial haemophagocytic reticulosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Familial hemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Familial hemophagocytic lymphohistiocytosis. Primary hemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

The epidemiology of Langerhans cell histiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Langerhans cell histiocytosis: an exploratory epidemiologic study of 177 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Epidemiologic study of Langerhans cell histiocytosis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Association of Langerhans cell histiocytosis with malignant neoplasms.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

The relation of Langerhans cell histiocytosis to acute leukemia, lymphomas, and other solid tumors. The LCH-Malignancy Study Group of the Histiocyte Society

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Acute promyelocytic leukemia with t(15;17) abnormality after chemotherapy containing etoposide for Langerhans cell histiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Langerhans cell histiocytosis in monozygotic twins

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Eosinophilic granuloma of the skull in identical twins--case report

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Familial Occurrence of Letterer-Siwe Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Hereditary Langerhans cell histiocytosis: instances of apparent vertical transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Monozygotic twins with congenital acute lymphoblastic leukemia (ALL) and t(4;11)(q21;q23)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Intrauterine monoclonal origin of neonatal concordant acute lymphoblastic leukemia in monozygotic twins

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Fetal origins of the TEL-AML1 fusion gene in identical twins with leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

t(11;22)(q23;q11.2) In acute myeloid leukemia of infant twins fuses MLL with hCDCrel, a cell division cycle gene in the genomic region of deletion in DiGeorge and velocardiofacial syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Langerhans'-cell histiocytosis (histiocytosis X)--a clonal proliferative disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Lack of T-cell receptor gene rearrangements in cells involved in Langerhans cell histiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

An update on clonality, cytokines, and viral etiology in Langerhans cell histiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Evidence for a polyclonal nature of the cell infiltrate in sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Clonal T-cell populations in lymphomatoid papulosis. Evidence of a lymphoproliferative origin for a clinically benign disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

A flow cytometric study of Langerhans cell histiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Progressive Langerhans cell histiocytosis in an infant with Klinefelter syndrome successfully treated with allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Cytogenetic abnormalities in Langerhans cell histiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

TEL gene rearrangements in myeloid malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Detection of the Der (21)t(12;21) chromosome forming the TEL-AML1 fusion gene in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

High frequency of t(12;21) in childhood acute lymphoblastic leukemia detected by RT-PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Comparison of peanut agglutinin and S100 stains in the paraffin tissue diagnosis of Langerhans cell histiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Langerhans' cell histiocytosis (histiocytosis X): immunophenotype and growth fraction

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Expression of GM-CSF receptor by Langerhans' cell histiocytosis cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Monokine expression in Langerhans' cell histiocytosis and sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Histiocytosis X. Purified (T6+) cells from bone granuloma produce interleukin 1 and prostaglandin E2 in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Elevated circulating levels of interleukin-1 receptor antagonist but not IL-1 agonists in hemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

1 reference

7 January 2021

Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Familial hemophagocytic lymphohistiocytosis (FHLH) in Israel. I. Description of 11 patients of Iranian-Iraqi origin and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Haemophagocytic lymphohistiocytosis: experience at two U.K. centres

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Clonal and non-clonal karyotypically abnormal cells in haemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Familial hemophagocytic lymphohistiocytosis macrophages showing immunohistochemical properties of activated macrophages and T-accessory cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Characteristic immune abnormalities in hemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Impaired natural killer activity and expression of interleukin-2 receptor antigen in familial erythrophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Defective natural killer cell function in patients with hemophagocytic lymphohistiocytosis and in first degree relatives

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Clinical, immunological, and pathological consequences of Fas-deficient conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Lymphohistiocytosis: a multi-factorial syndrome of macrophagic activation clinico-pathological study of 38 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Heterogeneity of immune markers in hemophagocytic lymphohistiocytosis: comparative study of 9 familial and 14 familial inheritance-unproved cases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Cytokines in hemophagocytic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Immunoregulation by interleukin-12.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Interleukin-12 regulates the proliferation of Th1, but not Th2 or Th0, clones.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Effect of trimethoprim-sulphamethoxazole in langerhans' cell histiocytosis: Preliminary observations

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Current therapy for Langerhans cell histiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Controversies and new approaches to treatment of Langerhans cell histiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Langerhans cell histiocytosis and hypercalcemia: clinical response to indomethacin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Results of treatment of 127 patients with systemic histiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Radiation therapy in soft-tissue lesions in histiocytosis X (Langerhans' cell histiocytosis).

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

The Pathogenesis, Diagnosis, and Treatment of Histiocytosis Syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Topical nitrogen mustard: An effective treatment for cutaneous Langerhans cell histiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

The effect of phototherapies on cutaneous lesions of histiocytosis X in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Satisfactory remission achieved by PUVA therapy in Langerhans cell hisiocytosis in an elderly patient

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Langerhans cell histiocytosis of the skin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Histiocytosis X--comparison of three treatment regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Langerhans cell histiocytosis in childhood: results from the Italian Cooperative AIEOP-CNR-H.X '83 study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

[Langerhans cell histiocytosis in childhood--results of the DAL-HX 83 study]

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Diabetes insipidus in Langerhans cell histiocytosis: results from the DAL-HX 83 study.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Langerhans cell histiocytosis: the case for conservative treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Diabetes insipidus secondary to Langerhans' cell histiocytosis: is radiation therapy indicated?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

LCH-I: a randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis. The Histiocyte Society.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Dose-escalation trial of cladribine using five daily intravenous infusions in patients with advanced hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Successful treatment of two children with Langerhans' cell histiocytosis with 2'-deoxycoformycin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

2-Chlorodeoxyadenosine to treat refractory histiocytosis X.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Nucleoside transporters, bcl-2 and apoptosis in CLL cells exposed to nucleoside analogues in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Heterogeneity of immunological patterns in Langerhan's histiocytosis and response to crude calf thymic extract in 11 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Interleukin-2 therapy of Langerhans cell histiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Cyclosporine therapy for refractory Langerhans cell histiocytosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Treatment of Langerhans cell histiocytosis with alpha-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Histiocytosis X: successful treatment with recombinant interferon-alpha A

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Remission of Langerhans cell histiocytosis with thalidomide treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Adult cutaneous Langerhans cell histiocytosis: remission with thalidomide treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Allogeneic bone marrow transplantation in a patient with chemotherapy-resistant progressive histiocytosis X.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Allogeneic bone marrow transplantation for Langerhans' cell histiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Allogeneic bone marrow transplantation in a patient with chemotherapy-resistant progressive histiocytosis X

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

A multicentre retrospective survey of Langerhans' cell histiocytosis: 348 cases observed between 1983 and 1993. The French Langerhans' Cell Histiocytosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

The contribution of marker gene studies to hemopoietic stem cell therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Genetic marking and manipulation of hematopoietic progenitor cells using retroviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Gene-marking to trace origin of relapse after autologous bone-marrow transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Sclerosing cholangitis and histiocytosis X.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Clinical spectrum of X-linked hyper-IgM syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Ulcerative colitis disease activity following treatment of associated primary sclerosing cholangitis with cyclosporin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Pediatric liver transplantation for Langerhans' cell histiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Liver transplantation for Langerhans' cell histiocytosis--a case report and literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Corticosteroids and the treatment of idiopathic pulmonary fibrosis. Past, present, and future

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Central nervous system disease in Langerhans cell histiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Radiation therapy for diabetes insipidus caused by Langerhans cell histiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Diabetes insipidus associated with Langerhans cell histiocytosis: is it reversible?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

The treatment of familial erythrophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Use of VP-16-213 in the treatment of familial erythrophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Successful treatment of lymphohistiocytic reticulosis with phagocytosis with epipodophyllotoxin VP 16-213.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Successful induction with chemotherapy including teniposide in familial erythrophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Immunosuppression: preliminary results of alternative maintenance therapy for familial hemophagocytic lymphohistocytosis (FHL)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Allogeneic bone marrow transplantation for erythrophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Treatment of familial lymphohistiocytosis: chemotherapy or bone marrow transplant?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Successful bone marrow transplantation from an HLA-identical unrelated donor in a patient with hemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Partial engraftment of donor bone marrow cells associated with long-term remission of haemophagocytic lymphohistiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

A framework for understanding and responding to the psychosocial needs of children with Langerhans cell histiocytosis and their families

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Familial hemophagocytic lymphohistiocytosis: improved neurodevelopmental outcome after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Deficient peptide loading and MHC class II endosomal sorting in a human genetic immunodeficiency disease: the Chediak-Higashi syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

The physical and genetic map surrounding the Lyst gene on mouse chromosome 13.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Griscelli disease maps to chromosome 15q21 and is associated with mutations in the myosin-Va gene

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900039-8

7 January 2021

10.1016/S0959-8049(99)00039-8

Identifiers

DOI

1 reference

29 July 2017

1 reference